PremiumThe FlyBiotech Alert: Searches spiking for these stocks today FREQ Skyrockets on Merger Deal with Korro Bio Frequency Therapeutics, Korro Bio to merge in all-stock transaction PremiumThe FlyFrequency Therapeutics downgraded to Perform from Outperform at Oppenheimer Frequency Therapeutics price target lowered to $4 from $10 at Baird Cowen downgrades Frequency to Market Perform as FX-322 study misses endpoint PremiumThe FlyFrequency announces FX-332 study misses endpoint, to reduce personnel by 55% Frequency Therapeutics doses first patient in FX-345 study Frequency Therapeutics management to meet virtually with Oppenheimer 
